Active Pharmaceutical Ingredients
Progestogen and Estrogen | |||
Product Name | Specification | Approved | CAS No. |
Progesterone | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone |
In-house |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
Megestrol Acetate | CP/EP/USP | DMF in process | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
Norethisterone |
CP/EP/USP/JP |
DMF in process |
68-22-4 |
Norethisterone Acetate |
EP/USP |
DMF in process |
51-98-9 |
Norethisterone Enanthate |
In-house |
Under R&D |
3836-23-5 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol Valerate | CP/EP/USP/KP | DMF | 979-32-8 |
Estradiol Cypionate |
USP |
DMF in process |
313-06-4 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP/GMP | 65928-58-7 |
Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
Exemestane | CP/EP/USP | Under R&D | 107868-30-4 |
Androgen | |||
Product Name | Specification | Approved | CAS No. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Darolutamide |
In-house |
Under R&D |
1297538-32-9 |
Testosterone | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
Testosterone Cypionate | USP | Under R&D | 58-20-8 |
Testosterone Enanthate |
USP/JP |
Under R&D |
315-37-7 |
Testosterone Propionate |
CP/EP/USP/JP |
Under R&D |
57-85-2 |
DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF in process | 19608-29-8 |
Cortical Hormone | |||
Product Name | Specification | Approved | CAS No. |
Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
Desonide | CP/USP | DMF/GMP | 638-94-8 |
Eplerenone | EP | CEP in process | 107724-20-9 |
Methylprednisolone | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | CP/EP | DMF in process | 397864-44-7 |
Mometasone Furoate |
CP/EP/USP |
DMF in process |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
Deflazacort |
In-house |
Under R&D |
14484-47-0 |
Others | |||
Product Name | Specification | Approved | CAS No. |
Oxcarbazepine | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
Eslicarbazepine Acetate | CP/USP | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP/EP | CEP in process | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | CP/EP | DMF | 223673-61-8 |
Vibegron |
In-house |
Under R&D |
1190389-15-1 |
Escitalopram Oxalate | CP/EP/USP | DMF in process | 219861-08-2 |
Citalopram Hydrobromide |
CP/EP/USP |
DMF in process |
59729-32-7 |
Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
Lasmiditan Succinate | In-house | DMF | 439239-92-6 |
Luliconazole | In-house | DMF | 187164-19-8 |
Apalutamide | In-house | DMF | 956104-40-8 |
Tadalafil | CP/EP/USP | Under R&D | 171596-29-5 |
Relugolix | In-house | DMF in process | 737789-87-6 |
Ruxolitinib phosphate |
In-house |
DMF in process |
1092939-17-7 |
Abemaciclib |
In-house |
Under R&D |
1231929-97-7 |
Phloroglucinol | CP/EP | DMF | 108-73-6 |
1,3,5-Trimethoxybenzene |
CP/In-house |
GMP |
621-23-8 |
Ursodeoxycholic Acid | EP/USP/JP | Under R&D | 128-13-2 |
Tauroursodeoxycholic Acid |
In-house |
Under R&D |
14605-22-2 |
Cholesterol |
CP/EP/USP/JP |
Under R&D |
57-88-5 |
Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF in process |
—— |
Medium-Chain Triglycerides |
CP/USP/EP |
DMF |
—— |
Benzalkonium Chloride |
USP/EP/JP |
CEP in process |
8001-54-5 |
Olive Oil (For Injection) |
CP/USP/EP/JP |
DMF in process |
8001-25-0 |
Egg phospholipids (For Injection) |
CP/USP/EP |
DMF |
93685-90-6 |
SNAC |
In-house |
DMF in process |
203787-91-1 |
Ang progesterone ay may mga detalye ng EP, USP, CP, JP, IP at KP. Available ang CEP, inaprubahan ng EU-GMP, FDA.
Ang Finasteride ay may EP, USP, CP, IP, JP na mga detalye. Available ang CEP, inaprubahan ng FDA, PMDA at GMP.
Ang Budesonide ay may mga detalye ng USP, EP. Inaprubahan ng CEP, GMP at FDA.
Ang Dutasteride ay may EP, USP, CP, IP, JP na detalye. Available ang CEP at FDA.
Ang Desonide ay may mga detalye ng USP at EP. Available ang DMF.
Ang Methylprednisolone ay may mga detalye ng USP, EP, IP, JP at KP. Available ang DMF at WC.